1. Home
  2. HNVR vs AGEN Comparison

HNVR vs AGEN Comparison

Compare HNVR & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Bancorp Inc.

HNVR

Hanover Bancorp Inc.

SELL

Current Price

$23.33

Market Cap

153.5M

Sector

Finance

ML Signal

SELL

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$2.94

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNVR
AGEN
Founded
2008
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
147.4M
IPO Year
2022
1999

Fundamental Metrics

Financial Performance
Metric
HNVR
AGEN
Price
$23.33
$2.94
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$24.50
$14.50
AVG Volume (30 Days)
71.5K
602.3K
Earning Date
04-27-2026
05-12-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
100.00
EPS
0.25
1.02
Revenue
N/A
$42,877,086.00
Revenue This Year
$35.49
$107.63
Revenue Next Year
$8.61
N/A
P/E Ratio
$93.12
$2.94
Revenue Growth
N/A
89.95
52 Week Low
$19.91
$2.71
52 Week High
$24.55
$7.34

Technical Indicators

Market Signals
Indicator
HNVR
AGEN
Relative Strength Index (RSI) 49.43 40.29
Support Level $21.89 $2.93
Resistance Level $24.27 $3.15
Average True Range (ATR) 0.84 0.22
MACD -0.07 -0.01
Stochastic Oscillator 50.29 20.90

Price Performance

Historical Comparison
HNVR
AGEN

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: